EXOSC9 and cancer: Thus, we set 343 EXOSC9-target gene candidates including APOBEC3G in MDA-MB-231 cells as the “EXOSC9 target signature” and evaluated the correlation between this signature and cancer patient prognosis using the TCGA datasets.